Table 4.

Risk Ratios for Prevalent Diabetes by Category of Baseline Level of Generalized Anxiety (GAD-7) or Depression (PHQ-9) Symptomatology

	MEN (n=425)			WOMEN (n=625)
ANXIETY SYMPTOMS
Model*	Low Symptomatology (0–9)† Diabetes Prevalence 59/373 (16%)	Moderate Symptomatology (10–14)† Diabetes Prevalence 4/30 (13%)	High Symptomatology (15+)† Diabetes Prevalence 2/22 (9%)	Low Symptomatology (0–9)† Diabetes Prevalence 111/519 (21%)	Moderate Symptomatology (10–14)† Diabetes Prevalence 5/69 (7%)	High Symptomatology (15+)† Diabetes Prevalence 11/37 (30%)	P–value for interaction‡
1.	1.0	0.97 (0.31,3.00)	0.12 (0.02,0.60)	1.0	0.23 (0.05,0.96)	1.80 (0.84,3.86)	0.14
2.§	1.0	1.27 (0.25,6.49)	0.24 (0.02,2.42)	1.0	0.15 (0.04,0.59)	1.62 (0. 61,4.32)	<0.001
DEPRESSION SYMPTOMS
	Low Symptomatology (0)† Diabetes Prevalence 42/261 (16%)	Moderate Symptomatology (1–2)† Diabetes Prevalence 11/80 (14%)	High Symptomatology (3+)† Diabetes Prevalence 12/84 (14%)	Low Symptomatology (0)† Diabetes Prevalence 48/275 (17%)	Moderate Symptomatology (1–2)† Diabetes Prevalence 36/169 (21%)	High Symptomatology (3+)† Diabetes Prevalence 43/181 (24%)	P-value for interaction‡
1.	1.0	1.16 (0.44,3.09)	0.74 (0.31,1.78)	1.0	1.21 (0.61,2.40)	1.48 (0.85,2.59)	0.23
2.||	1.0	1.01 (0.31,3.29)	1.30 (0.46,3.68)	1.0	1.91 (0.90,4.06)	2.32 (1.10,4.89)	0.16

The Detroit Neighborhood Health Study, 2008–2010 (n=1,050)

^*Mode 1: Crude; Model 2: adjusted for age, race, marital status, employment status, education level, lifetime depression or lifetime GAD, smoking status, and binge drinking

^†Range of generalized anxiety disorder (GAD)-7 or patient health questionnaire (PHQ)-9 scores within categories of symptomatology according to clinical cut-points

^‡P-value for interaction with ordinal depression interaction term.

^§P-values for linear trend for anxiety in model 2 among Men: 0.70 & Women: 0.93

^||P-values for linear trend using for depression in model 2 among Men: 0.75 & Women: 0.02